New Cell Therapy Guide Highlights The Importance Of Skyland PIMS
Source: IDBS UK HQ

Cell and gene therapies are helping treat, and potentially cure, a range of conditions that have been untouched by small molecule and biologic agents. A new case study, Project A-Cell, highlights best practices and a standard methodology for Chemistry, Manufacturing and Controls (CMC) to the cell-based therapy field. Here we discuss the critical systems that enable enterprise control in cell-based therapy manufacturing. One of these systems is Process Information Management (PIMS).
Learn more about the cell therapy manufacturing process and where Skyland PIMS can support your organization.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
IDBS UK HQ
This website uses cookies to ensure you get the best experience on our website. Learn more